Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Researchers from across the Medical Sciences Division are working hard to combat the COVID-19 crises. With particular strengths in infectious diseases and international health, we are well placed to contribute to better understanding and effectively controlling the epidemic. We have a long history of responding to crises, in the UK and around the world and are leaders in emergency vaccine development. During the 2014 Ebola outbreak, our scientists performed the world’s first human Ebola vaccine studies, starting them before any other university or company. Our researchers, in collaboration with partners across the globe, are working to develop an effective vaccine and drugs to target this virus, and have already introduced innovative public health measures and collaborative online tools that are being used in hospitals here and abroad.

Coronavirus-related news from across the Medical Sciences Division

The economic impact of COVID-19

In this Centre for Tropical Medicine & Global Health (Nuffield Department of Medicine) blog, Rima Shretta (Honorary Visiting Research Fellow) outlines the direct and indirect costs of the COVID-19 pandemic which may impact the global economy.

BRC funds new COVID-19 research projects

The NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to three COVID-19 research projects in an attempt to improve treatment, understand how the virus interacts with chronic diseases, and the longer-term effects of infection on organs.

NHS staff across England get free access to wellbeing apps

NHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.

Public appeal raises £50,000 (and counting) for Oxford’s COVID-19 research

An online fundraising appeal for coronavirus (COVID-19) research at Oxford has raised more than £50,000 from over 200 individuals after launching just two weeks ago. The donations will be deployed immediately, boosting projects ranging from vaccine development to the delivery of new drugs to treat the virus.

Controlling coronavirus transmission using a mobile app to trace close proximity contacts

A team of medical researchers and bioethicists at Oxford University has published results today in Science that further our understanding of coronavirus transmission.

COVID-19 Therapeutics Accelerator awards $20 million in initial grants to fund clinical trials

Researchers at Mahidol Oxford Tropical Medicine Research Unit (MORU) and two institutions in the US (University of Washington and La Jolla Institute for Immunology) receive grants from the COVID-19 Therapeutics Accelerator, a large-scale initiative launched by the Bill & Melinda Gates Foundation, Wellcome and Mastercard to speed the development of and access to therapies for COVID-19.

GP practices urged to join COVID-19 research

The Nuffield Department of Primary Care Health Sciences at the University of Oxford and the Royal College of General Practitioners (RCGP) have joined forces with clinical system supplier EMIS Health to urgently recruit as many GP practices as possible for COVID-19 research.

COVID-19's impact on youth mental health the focus of new research

COVID-19 has led to an elevated awareness of threat in the environment and has caused major disruptions to families’ lives, through social distancing, school closures, and now effective lock-down. A new research survey, launched today from experts at the University of Oxford, will track children and young people’s mental health throughout the COVID-19 crisis to identify what advice, support and help can actually protect their mental health.